|
National Stock Number(NSN): 6505-01-312-0915 (6505013120915, 013120915)
| NIIN: |
01-312-0915 |
Item Name: |
SULFAMETHOXAZOLE AND TRIMETHOPRIM INJECTION1 |
INC: |
36014
|
| FSC: |
6505
|
Assignment Date: |
Dec-10-1989 |
CRIT: |
N |
IIG: |
36014 |
| ISC: |
2 |
Date Standardized: |
Dec-10-1989 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-01-2000 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
811 |
5P291
|
BURROUGHS WELLCOME CO GOVERNMENT GROUP PURCHASING SALES |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
9-0671 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00081-0856-47 |
5P291
|
BURROUGHS WELLCOME CO GOVERNMENT GROUP PURCHASING SALES |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
SEPTRA |
5P291
|
BURROUGHS WELLCOME CO GOVERNMENT GROUP PURCHASING SALES |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
SEPTRA ADD-VANTAGE |
5P291
|
BURROUGHS WELLCOME CO GOVERNMENT GROUP PURCHASING SALES |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
K |
U |
1 |
A |
$30.00 |
PG |
|
C2201X- |
Oct-01-1994 |
H |
| DF |
JDC |
L |
|
K |
U |
1 |
F |
$69.49 |
PG |
|
------- |
Mar-01-1996 |
H |
| DM |
JDC |
L |
Z |
K |
U |
1 |
M |
$69.49 |
PG |
|
1-54--- |
Mar-01-1996 |
H |
| DN |
JDC |
L |
|
K |
U |
1 |
N |
$69.49 |
PG |
|
9L----- |
Mar-01-1996 |
H |
| DS |
JDC |
L |
|
K |
U |
1 |
D |
$69.49 |
PG |
|
------- |
Mar-01-1996 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
800.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 160.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
9.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.23 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
10 |
| FEAT |
SPECIAL FEATURES |
15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715 |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUCB |
UNIT OF ISSUE CUBE |
0.02 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.90 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jan-05-2000 |
3 |
H |
|
|
|
|
| FSKX |
|
Jan-05-2000 |
3 |
H |
|
|
|
|
| MC15 |
|
Jan-05-2000 |
3 |
H |
|
|
|
|
| N9LM |
|
Jan-05-2000 |
3 |
H |
|
|
|
|
|